RSSearch Patient Registry for SRS/SBRT Treatments

This study, called the RSSearch Patient Registry, is collecting information long-term about how Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) are used and how well they work. These are types of radiation therapy. The registry aims to understand the most effective ways to use SRS/SBRT for conditions like tumors (neoplasms), brain arteriovenous malformations (a tangle of abnormal blood vessels), and trigeminal neuralgia (a chronic pain condition). Researchers will track patient characteristics, treatment plans, and outcomes like overall survival for up to 5 years. You can join if you have a condition that can be treated with SRS/SBRT and are willing to sign an informed consent form. This is an observational study, meaning researchers are watching and recording information, not testing a new treatment. The study is actively enrolling a large number of participants.

Study design
This is an observational study designed to collect information from up to 50,000 participants. It is not testing a new treatment but rather observing current practices and outcomes.
What's involved
You would need to sign an Informed Consent Document or verbally agree to participate. The study will record information about your treatment and outcomes.
Compensation
Not stated in the trial record.
Follow-up
The study will track outcomes, such as overall survival, for up to 5 years after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01885299

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Recruiting
Not specifiedAll AgesObservational
The Radiosurgery Society
~50,000 participants
Updated 2024-09-19 on ClinicalTrials.gov
What's tested:SRS/SBRT

At a glance

Recruiting sites
2 of 13 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Overall survival
Measured over Up to 5 years
Neoplasms
Arteriovenous Malformation of Central Nervous System
Trigeminal Neuralgia
13 sites across 9 states
New Jersey3
Pennsylvania3
Colorado1
Florida1
Georgia1
Michigan1
New York1
Tennessee1
  • Anand Mahadevan, MD · STUDY_DIRECTOR · The Radiosurgery Society

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
Willingness to sign an Informed Consent Document or verbally agree to participation
  • Overall survivalUp to 5 years

    Survival from time of treatment to death